CompoAtlas

Genestra Brands TM Femagen PMS Tablets

Genestra Brands TM Femagen PMS Tablets, NPN 80038623: natural health product licensed in Canada. Medicinal ingredients: Vitamine B6, Dioscorea villosa, Bos taurus, Folate.

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Vitamine B6

Source : Chlorhydrate de pyridoxine

50 mg100,000 µg
Dioscorea villosa

Source : Racine

10 mgNot calculated
Bos taurus

Source : Adrenal

25 mgNot calculated
Folate

Source : Acide folique

150 mcgNot calculated
bêta-carotène

Source : bêta-carotène

Potency : 2,000 UI

1,200 mcgNot calculated
Taraxacum officinale

Source : Feuille

10 mgNot calculated
Caulophyllum thalictroides

Source : Racine

15 mgNot calculated

Non-medicinal ingredients

Acide stéarique, Dioxyde de silicium, Stéarate de magnésium, Cellulose, microcristalline

PopulationAgeQuantity per servingFrequency
Adultes de sexe fémininNot specified1 Comprimé2 Tous les jours

Uses authorised in Canada

A factor in the maintenance of good health. Helps to relieve symptoms associated with premenstrual syndrome. A source of vitamin A to help maintain eyesight, skin, membranes and immune function; helps in the development and maintenance of bones and teeth; helps the body to metabolize carbohydrates, fats and proteins; helps normal growth; helps in tissue formation; helps to form red blood cells and helps in their proper function and helps to maintain proper muscle function.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Product record

Licence holder
Seroyal International
NPN or DIN-HM
80038623
Status
Active licence
Licence date
10 January 2013
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Non traditionnelle

Source

Official Health Canada record, licence 80038623

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Genestra Brands TM Femagen PMS Tablets (Seroyal International): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80038623-genestra-brands-tm-femagen-pms-tablets, updated 10 January 2013.

Enter to analyse, Shift+Enter for a new line